Asensus Surgical, Inc. (ASXC) Reports In-Line Q2 EPS

Asensus Surgical, Inc. (NYSE: ASXC) reported Q2 EPS of ($0.08), in-line with the analyst estimate of ($0.08). Revenue for the quarter came in at $1 million versus the consensus estimate of $1.25 million.

For earnings history and earnings-related data on Asensus Surgical, Inc. (ASXC) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Vislink Technologies Inc. (VISL) Misses Q2 EPS by 7c